Kai-Hua, Edward Chow

Chow Kai-Hua, Edward

Appointment(s)
  • Assistant Professor, Department of Surgery
  • Consultant, Department of Cardiac, Thoracic & Vascular Surgery, University Surgical Cluster, National University Health System
Administrative Appointment(s)
  • Principal Investigator, Cancer Science Institute of Singapore, National University of Singapore
Academic Qualifications
  • PhD, University of California, Los Angeles, USA
  • BA, University of California, Berkeley, USA
Research Interest(s)
  • Cancer Stem Cells
  • Nanomedicine
  • Therapeutic Combination Optimisation
  • Epigenetics
  • Hematologic Malignancies
Recent Publications
  • 1. Chow EK. Feb 2013. Implication of Cancer Stem Cells in Cancer Drug Development and Drug Delivery. J Lab Autom.18(1):6-11. doi: 10.1177/2211068212454739. Epub Aug 2012 14. 22893634.
  • 2. Chow EK, Zhang XQ, Chen M, Lam R, Robinson E, Huang H, Schaffer D, Osawa E, Goga A, Ho D. Mar2011. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment. Science Translational Medicine. 9;3(73):73ra21. doi: 10.1126/scitranslmed.3001713. 21389265.
  • 3. Chow EK, Fan L, Chen X, Bishop JM. Oct 2012. Oncogene-specific formation of chemoresistant murine hepatic stem cells; Hepatology.56(4):1331-41. doi: 10.1002/hep.25776. Epub 2012 Aug 27. 22505225.
  • 4. Zhang XQ, Lam R, Xu X, Chow EK, Kim H, Ho D. Nov 2011. Multimodal Nanodiamond Drug Delivery Carriers for Selective Targeting, Imaging and Enhanced Chemotherapeutic Efficacy. Adv Mater. 23(41):4770-5. doi: 10.1002/adma.201102263. Epub 2011 Sep 20. 21932280.
  • 5. Ghaffari A, Chow EK (co-first), Shankar I, Deng JC, Cheng G. Jun 2011. PolyI:C Suppresses Acetaminophen-Induced Hepatotoxicity Independent of Type I Interferons and Toll-Like Receptor 3. Hepatology. 53(6):2042-52. doi: 10.1002/hep.24316. 21433044.